| Original language | English (US) |
|---|---|
| Pages (from-to) | 1138-1140 |
| Number of pages | 3 |
| Journal | Leukemia |
| Volume | 37 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2023 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Leukemia, Vol. 37, No. 5, 05.2023, p. 1138-1140.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study
AU - Gossai, N.
AU - Bhojwani, D.
AU - Schafer, E. S.
AU - Chang, B. H.
AU - Pommert, L.
AU - Verma, A.
AU - Malvar, J.
AU - Chi, Y. Y.
AU - Hitzler, J.
AU - Burke, M. J.
AU - Rabin, K. R.
N1 - Funding Information: We thank the patients and families who participated in this study. We also acknowledge the TACL Consortium’s scientific contribution to and participation in this study, including participating member institutions, investigators, research teams, and the TACL Operations Center. This trial was supported by partial funding from Higgins Charitable Foundation (DB), Bear Necessities, Pediatric Cancer Foundation (MJB), Children’s Cancer Research Fund (CCRF) (MJB), Midwest Athletes Against Childhood Cancer (MACC) Fund (MJB), The Medical College of Wisconsin Cancer Center—Advancing Healthier Wisconsin Partnership Program (MJB), and the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL007209 (LP). Funding Information: We thank the patients and families who participated in this study. We also acknowledge the TACL Consortium’s scientific contribution to and participation in this study, including participating member institutions, investigators, research teams, and the TACL Operations Center. This trial was supported by partial funding from Higgins Charitable Foundation (DB), Bear Necessities, Pediatric Cancer Foundation (MJB), Children’s Cancer Research Fund (CCRF) (MJB), Midwest Athletes Against Childhood Cancer (MACC) Fund (MJB), The Medical College of Wisconsin Cancer Center—Advancing Healthier Wisconsin Partnership Program (MJB), and the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL007209 (LP).
PY - 2023/5
Y1 - 2023/5
UR - http://www.scopus.com/inward/record.url?scp=85148507259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148507259&partnerID=8YFLogxK
U2 - 10.1038/s41375-023-01856-6
DO - 10.1038/s41375-023-01856-6
M3 - Article
C2 - 36813993
AN - SCOPUS:85148507259
SN - 0887-6924
VL - 37
SP - 1138
EP - 1140
JO - Leukemia
JF - Leukemia
IS - 5
ER -